January 2, 2023 — The U.S. Food and Drug Administration (FDA) has approved the BioFreedom Drug Coated Coronary Stent (DCS) System – P190020 from Biosensors International. The BioFreedom Drug Coated Coronary Stent System is intended to treat a narrowed blood vessel (coronary artery) caused by coronary artery disease.

January 2, 2023 — The U.S. Food and Drug Administration (FDA) has given the approval to market to The Edwards Lifesciences PASCAL Precision Transcatheter Valve Repair System. The PASCAL Precision Transcatheter Valve Repair System is used to repair the mitral valve of the heart without the need for open-heart surgery.  The device system includes a permanent implant and a delivery system.

The DAIC team wishes you a very happy and safe New Year! 

December 30, 2022 — The Cardiovascular Research Foundation (CRF) recently announced that Alexandra Popma, MD, has joined the organization as Executive Director of the CRF Clinical Trials Center (CTC).

December 30, 2022 — Azmi Atiya, MD, an established and highly respected cardiothoracic surgeon in the San Fernando Valley, has joined the 

December 30, 2022 — NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced the first installation of its SmartMSU with OmniTom Elite – a specialized ambulance that is equipped with a small computed tomography (CT) scanner for head imaging – in the Asia-Pacific region.

December 29, 2022 — Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease (PAD), welcomes a new managing physician, Alexander Shestopalov, MD, Vascular and Interventional Radiologist to its clinic serving the greater Houston area at 

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer. Anthracyclines — such as doxorubicin, frequently used against breast cancer — kill cancer cells by damaging their DNA.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now